PCOS: Patient Advocacy Meets Frustration PCOS dominated off-label GLP-1 discussions with over 11.4k mentions
A better model than replacing one threshold with another The nuance here is not that everyone should be pushed early and hard to a single advanced marker target
ran a full phenotypic characterization of ASCs harvested from the thighs of lipedema patients, comparing them to both intra-patient abdominal ASCs and those from healthy controls
Well, our liver loves to create some glucose when it senses glucagon
POTENTIAL APPLICATIONS IN OTHER INFLAMMATORY CONDITIONS Studies suggest possible therapeutic roles influencing chronic respiratory conditions, joint inflammation, and other immune system disorders
It is the key regulator of insulin-like growth factor 1 (IGF1), which is secreted from target tissues, particularly the liver